Ethics, policy, and legislation

Christian Rodriguez, Charlotte E. Blattner, Angela K. Martin. How ignoring the harm of killing undermines the ethical legitimacy of animal research: a case study from Switzerland. Medicine, Health Care and Philosophy. 2026. doi:10.1007/s11019-026-10382-y

Tyna Dao, Nakissa Sadrieh. A CDER perspective: Landscape of New Approach Methodologies (NAMs) submitted in drug development programs. Regulatory toxicology and pharmacology: RTP. 2026;165:106007. doi:10.1016/j.yrtph.2025.106007

kathrynlm. Should patients have a say in the authorisation of animal experiments? https://blogs.bmj.com/medical-ethics/2026/08/06/should-patients-have-a-say-in-the-authorisation-of-animal-experiments/. Published 2026.

Jill Monnissen, Andreas De Block. Exploring ethical reasoning and welfare perceptions of Octopus vulgaris paralarvae among scientific and non-scientific communities. Laboratory Animals. 2026:00236772261441121. doi:10.1177/00236772261441121

ISoOR Insight Team. United Kingdom Launches £75 Million National Roadmap to Phase Out Animal Testing by 2030: A Defining Moment for Human-Relevant Research. Journal of Organoid and Bioscience. 2026;3(1). https://jobs.isoor.org/index.php/journal/article/view/59.

Ksenia Blinova, Kimberly Chiu, Anik Chaturbedi, et al. Advances in New Approach Methodologies at FDA’s Division of Applied Regulatory Science. Clinical Pharmacology and Therapeutics. 2026;120(5):1250-1254. doi:10.1002/cpt.70472

Federico Germani, Julian W. März, Alessandro Luciani, Olivier Devuyst, Nikola Biller-Andorno. Ethical and legal considerations of digital animal models: pioneering reduction and replacement. Trends in Biotechnology. 2026;44(3):593-595. doi:10.1016/j.tibtech.2025.08.011

Benjamin Victor Ineichen. We need less animal research, better animal research, and animal research done for the right reasons. Journal of Translational Medicine. 2026. doi:10.1186/s12967-026-08259-y

Matthias Eggel, Samuel Camenzind, Paulin Jirkof. Reasons to Reduce Surplus Animals in Research (in Switzerland) – Or Why the Killing and Death of Animals and Potentially Standard Husbandry Conditions Should be Classified as Harms. LEOH - Journal of Animal Law, Ethics and One Health. 2026:1-15. doi:10.58590/leoh.2026.001

Donald E. Ingber. Challenges and opportunities for human Organ Chips in FDA assessments and pharma pipelines,. Cell Stem Cell. 2026. doi:10.1016/j.stem.2025.12.022